Revenue, 2026

USD 2.6 Billion

Forecast, 2036

USD 5.21 Billion

CAGR, 2027-2036

7.2%

Report Coverage

France

France Hospital-at-Home Services Market Size for 2027

The France hospital-at-home services market size is calculated at US$ 2.6 billion in 2026, grows to US$ 2.79 billion in 2027, and is projected to reach around US$ 5.21 billion by 2036, expanding at a CAGR of 7.2% from 2026 to 2035. France’s hospital-at-home services market is expanding as healthcare providers shift more complex medical care from hospitals to patients’ homes. The country recorded 7.2 million hospitalization-at-home (HAD) patient-days in 2023 and 7.7 million in 2024, representing approximately 6.9% growth based on rounded figures. This increase reflects rising demand for home-based clinical services and the growing role of HAD in France’s healthcare delivery system.

Market sizing requires a clear distinction between reimbursable HAD activity and the broader economic activity of home-based clinical services. Revenue calculations depend on patient volumes, care intensity, reimbursement tariffs, case mix, supplementary payments, and financing arrangements. The forecasting model incorporates patient-days, revenue per patient-day, case mix, and provider capacity. At an annual growth rate of 5-8%, patient-days reach approximately 9.8-11.3 million by 2030, based on six years of compound growth from 2024.

Population aging, rising chronic disease prevalence, hospital capacity constraints, and advances in home-based medical procedures drive market expansion. France’s regulated, reimbursement-based healthcare system distinguishes HAD from conventional homecare and consumer health services. Providers compete on their ability to deliver complex clinical care safely, maintain hospital and physician referral networks, recruit qualified medical and paramedical staff, manage medicines and medical devices, and operate efficiently within regulated reimbursement frameworks.

French HAD delivers coordinated medical and paramedical care at home under medical prescription, with a level of clinical intensity comparable to hospital care over a defined period. It differs from routine home nursing, personal assistance, independent nursing visits, and non-medical support for older adults. Market performance therefore depends on patient volumes, patient-days, care intensity, reimbursement by case mix, provider economics, clinical outcomes, and regional service coverage. These indicators provide a more reliable assessment of market expansion than homecare visit numbers or total industry revenue alone.

Key Coverage

• Revenue decomposition by tariff mix and clinical intensity.
• Simultaneous capacity, utilization, and average length of stay.
• Regional forecasts and provider-level growth contribution.
• Base, upside and downside assumptions.

Key Takeaways

• The France hospital-at-home services market will likely exceed USD 2.79 billion by 2027.
• Valuation is projected to hit USD 5.21 billion by 2036.
• Estimated to grow at a CAGR of 7.2% starting from 2026 to 2036.
• By service type, the medical and nursing care segment dominated the market in 2025.
• By clinical application, the infectious diseases segment is expected to grow at the fastest CAGR during the forecast period.
• By patient age group, the pediatric patients segment is expected to grow at the fastest CAGR during the forecast period.
• By care setting, the nursing homes and long-term care facilities (EHPAD) segment is expected to grow at the fastest CAGR during the forecast period.
• By patient acuity and care complexity, the moderate-complexity clinical care segment dominated the market in 2025.
• By duration of care, the short-term care (less than 15 days) segment is expected to grow at the fastest CAGR during the forecast period.
• By referral source, the public hospitals and university hospital centers (CHUs) segment dominated the market in 2025.
• By provider type, the private nonprofit HAD providers segment dominated the market in 2025.
• By payment and reimbursement structure, the regulated HAD tariff-based reimbursement segment dominated the market in 2025.
• By technology, the electronic health records and digital care plans segment dominated the market in 2025.
• By care delivery model, the digitally supported and remote-monitoring-enabled care segment is expected to grow at the fastest CAGR during the forecast period.

Which clinical segments offer the strongest growth and value-creation opportunities in France’s hospital-at-home services market?

The strongest growth opportunities in France’s hospital-at-home services market lie in infectious disease care, pediatric care, and services delivered through nursing homes and long-term care facilities (EHPAD). Short-term care lasting less than 15 days also represents a high-growth segment, reflecting the market’s focus on shorter treatment episodes. Digitally supported care with remote monitoring presents another growth opportunity by strengthening patient monitoring and coordination of home-based treatment.

In 2025, medical and nursing care were dominated by service type, while moderate-complexity clinical care was led by patient acuity and care complexity. Public hospitals and university hospital centers (CHUs) dominated as referral sources, and private nonprofit HAD providers held the leading position by provider type. Regulated HAD tariff-based reimbursement and electronic health records with digital care plans also dominated their respective segments.

Value-creation opportunities depend on expanding high-growth services while improving care coordination, staffing efficiency, and clinical outcomes. Providers that strengthen partnerships with hospitals, develop services for pediatric patients and EHPAD residents, and integrate remote monitoring into care delivery are well positioned to address evolving demand across France’s hospital-at-home market.

Key Coverage

• Clinical-treatment mix and patient-day contribution.
• Age groups, dependency, and chronic disease burden.
• Residential versus EHPAD-based care.
• Episode length, readmission, and treatment intensity.
• Fast-growing clinical applications and unmet needs.
• Segment-specific reimbursement and cost-to-serve.

Market Dynamics: Hospital Capacity, Demographics, and Staffing Determine Realizable Growth

Demand for hospital-at-home (HAD) services is driven by population aging, multiple chronic conditions, shorter hospital stays, patient preference for care at home, and efforts to reduce avoidable hospital admissions. Medical and technological advances have expanded the range of treatments delivered safely in the home setting.

The main constraint is operational capacity. HAD providers need trained staff, broad geographic coverage, strong physician coordination, timely medication delivery, and rapid responses to patient deterioration. Staff shortages limit admissions and service expansion even when demand remains high.

Market growth also depends on referral networks. Hospitals, specialist departments, general practitioners, and residential care facilities need confidence in providers’ ability to admit patients promptly and maintain uninterrupted treatment. Differences in local clinical networks, referral practices, and service coverage create significant regional variations in growth potential, even where demographic demand is similar.

Key Coverage

• Ageing, chronic disease and hospital-discharge trends.
• Clinical eligibility and conversion from referral to admission.
• Workforce availability and staff productivity.
• Hospital substitution and avoidable inpatient days.
• Referral-network depth and local adoption barriers.
• Growth sensitivity to reimbursement and staffing scenarios.

Pricing Analysis: Case-Mix Reimbursement Rewards Appropriate Care, Not Simply Higher Patient-Day Volumes

French hospital-at-home (HAD) services operate under a regulated hospital funding system in which reimbursement depends on the clinical episode, treatment category, and services delivered. Per-patient-day reimbursement is not a uniform rate. Clinical intensity, treatment duration, and funding adjustments influence revenue per episode.

Provider profitability depends on the relationship between reimbursement and the cost of delivering care. Major operating costs include clinical staff, medicines, medical equipment, transportation, logistics, and standby staffing. High-intensity cases often generate higher reimbursement but also require greater resources and incur higher treatment costs.

The report compares effective reimbursement per patient-day, revenue per episode, direct clinical costs, staffing costs per day, pharmacy and equipment expenses, and operating margins across treatment categories. It also assesses how changes in case mix, staff costs, and travel intensity affect provider profitability.

Key Coverage

• Tariff-group structure and effective reimbursement.
• Revenue per episode and per patient-day.
• Direct clinical, pharmaceutical, and logistics costs.
• Contribution margin by care category.
• Price and cost sensitivity under reimbursement scenarios.
• Working-capital and cash-collection performance.

Demand-Supply Analysis: Authorized Capacity Is Not the Same as Deliverable Capacity

Demand for French hospital-at-home (HAD) services depends on patient eligibility, hospital discharge priorities, and the availability of providers equipped to deliver care at home. Expanding demand does not automatically translate into higher service volumes, as providers need sufficient clinical staff, geographic coverage, and operational resources to admit and treat patients safely.

Supply is constrained by the availability of clinical staff, physician prescribing relationships, and the ability to coordinate care beyond hospital settings. Long travel distances in rural areas increase costs per patient-day, while urban areas benefit from shorter travel routes but face greater demand and competition for healthcare professionals.

The analysis evaluates regional capacity and activity, patient-day productivity, staffing availability, and service coverage. It also identifies areas where limited adoption, workforce shortages, or weak referral coordination restrict service expansion despite underlying demand.

Key Coverage

• Authorized and operational capacity.
• Patient-days per available place and utilization.
• Workforce-adjusted supply and recruitment needs.
• Geographic gaps and regional capacity expansion.
• Referral backlogs, admission delays and discharge pathways.
• Investment requirements for incremental capacity.

Value Chain & Supply Chain: Clinical Integration Is the Principal Source of Differentiation

The hospital-at-home (HAD) value chain begins with patient referrals and eligibility assessments, followed by treatment planning, staff allocation, and medical equipment and medication delivery. Providers then deliver clinical care through home visits, telemonitoring, and direct medical assessments. The process concludes with escalation to higher levels of care when necessary and patient discharge after treatment completion.

Hospital-at-home services depend on locally coordinated care delivery. Value creation rests on reimbursement structures, treatment complexity, workforce productivity, medical supply availability, and coordination among hospitals, physicians, pharmacies, and care teams. Providers strengthen their competitive position through efficient resource allocation, continuity of care, and the ability to prevent avoidable readmissions and unnecessary hospital transfers.

Key Coverage

• Referral-to-discharge pathway and stakeholder economics.
• Clinical labor and outsourced-service exposure.
• Pharmacy, equipment, and medical-supply coordination.
• Procurement concentration and logistics efficiency.
• Care continuity, escalation, and quality assurance.
• Cost-to-serve and operational value-capture opportunities.

Technology, Regulation and Sustainability: Digital Coordination Supports Scale but Does Not Replace Clinical Capacity

Remote monitoring, electronic care plans, interoperable clinical records, digital scheduling, and clinical decision-support systems improve coordination and visibility across hospital-at-home (HAD) services. Their value depends on integration into clinical workflows and the ability to trigger timely interventions.

HAD providers operate under French healthcare requirements governing authorization, medical prescriptions, reimbursement, patient safety, data privacy, and care quality. Patient consent and clinical suitability are essential for treatment at home. HAD follows the applicable hospital funding framework, while routine home assistance does not automatically qualify as HAD.

Home-based care reduces inpatient stays and patient travel, but these savings must be weighed against staff travel, medication deliveries, equipment transport, and other operating costs. The study assesses digital maturity, system interoperability, cybersecurity, clinical governance, and operating conditions to identify where home-based care delivers measurable resource savings.

Key Coverage

• Remote monitoring and digital workflow adoption.
• Electronic records and interoperability.
• Authorization, patient consent and reimbursement compliance.
• Clinical quality, escalation and data protection.
• Staff travel, resource utilization and environmental impact.
• Investment priorities for scalable care delivery.

Segmental Analysis

By Service Type 2026 Share & Size

Medical and nursing care is estimated to remain the largest service category, reflecting its central role in hospital-at-home delivery. Palliative care, oncology support, infusion services, and post-surgical care also contribute significantly by enabling eligible patients to receive hospital-level treatment at home.

By Clinical Application 2026 Share & Size

Oncology and palliative care are estimated to account for substantial shares because patients may require ongoing symptom management, complex treatment support, and coordinated clinical monitoring. Infectious disease management is positioned as a potential growth area as home-based care pathways expand for clinically appropriate patients.

By Patient Age Group 2026 Share & Size

Adult patients are estimated to represent the largest share of current demand, supported by home-based treatment needs across acute and chronic conditions. Pediatric services may grow faster as care pathways for children requiring specialized monitoring and treatment at home develop.

By Care Setting 2026 Share & Size

Private residential homes are estimated to account for the largest share because hospital-at-home services are designed to deliver appropriate clinical care in patients’ own homes. EHPAD and other residential care settings are potential growth areas as providers coordinate more closely with healthcare professionals to manage complex care needs.

By Patient Acuity and Care Complexity 2026 Share & Size

Moderate-complexity clinical care is estimated to dominate the market, consistent with the need to provide hospital-level services at home while maintaining appropriate clinical oversight. High-complexity and specialized care also represent important segments where staffing, monitoring, and coordinated multidisciplinary support are essential.

By Duration of Care 2026 Share & Size

Short-term care is estimated to be the largest duration segment, reflecting acute treatment episodes, recovery support, and care following hospital discharge. Medium- and long-term services remain important for patients needing extended monitoring, complex treatment, or ongoing clinical support at home.

By Referral Source 2026 Share & Size

Public hospitals and university hospital centers are estimated to be the leading referral source because they coordinate inpatient discharge and transitions to home-based clinical care. Private hospitals, general practitioners, and specialists also contribute by identifying suitable patients and supporting continuity of treatment.

By Provider Type 2026 Share & Size

Private nonprofit hospital-at-home providers are estimated to hold the largest share, reflecting the role of nonprofit organizations in France’s home hospitalization landscape. Public hospital-based and private for-profit providers also serve important needs, while independent specialist organizations contribute targeted services and delivery capacity.

By Payment and Reimbursement Structure 2026 Share & Size

Regulated HAD tariff-based reimbursement is estimated to dominate the market because hospital-at-home services operate within France’s regulated healthcare financing framework. Supplementary funding and activity-related mechanisms may support specific services, while reimbursement arrangements influence provider capacity and service mix.

By Technology 2026 Share & Size

Electronic health records and digital care plans are estimated to lead the technology segment because providers need coordinated documentation, treatment plans, and information sharing across care teams. Remote monitoring and connected devices are important supporting technologies that may enable earlier identification of clinical changes and more digitally supported care.

By Care Delivery Model 2026 Share & Size

Multidisciplinary home-based clinical care is estimated to account for the largest share because hospital-at-home services often require coordinated input from nurses, physicians, and other healthcare professionals. Digitally supported and remote-monitoring-enabled care may grow rapidly as providers integrate connected devices and digital coordination into home-based treatment.

Competitive Landscape: Regional Clinical Networks and Operating Scale Shape Provider Advantage

The French hospital-at-home (HAD) market includes public hospitals, nonprofit specialist organizations, and private providers. Competitive positioning depends on reputation, geographic coverage, workforce capabilities, service range, and operational performance.

The market remains fragmented by geography and clinical partnerships. Large providers benefit from economies of scale across administration, technology, and purchasing. Local operators benefit from established referral relationships and a deeper understanding of regional healthcare needs. Neither model guarantees higher profitability. Broad geographic coverage increases travel and coordination costs, while a limited footprint restricts expansion opportunities.

Competitive benchmarking focuses on operational performance, including patient-days, annual admissions, average episode duration, capacity utilization, workforce productivity, revenue per patient-day, operating margins, and readmission rates. Provider-level financial analysis also separates HAD-specific revenue from total corporate revenue, particularly for organizations operating across multiple healthcare services.

Key Leading Company

Key Coverage

• Direct operators versus hospital groups and affiliated services.
• Public, nonprofit and private operating models.
• National, regional and local service footprints.
• Clinical specialization and referral relationships.
• Provider eligibility, operating scope and ownership verification.
• Market entry, consolidation and regional expansion prospects.

Product Portfolio and Application Benchmarking: The Breadth of Clinical Services Determines Addressable Demand

In the hospital-at-home (HAD) market, portfolio breadth reflects the range of clinical pathways a provider delivers safely and effectively. Benchmarking distinguishes generalist services from specialized care, including palliative care, oncology treatments, complex wound management, intravenous therapies, post-acute care, and support for patients with complex clinical needs.

A broader service portfolio strengthens referral opportunities and improves resource allocation across treatment pathways. However, specialized services require trained staff, dedicated equipment, effective medication management, and robust clinical governance. Portfolio expansion delivers value when local referral volumes, workforce capacity, and reimbursement levels support the additional operating costs.

Key Coverage

• Clinical service breadth and specialist capabilities.
• Treatment categories served by each provider.
• Advanced-care readiness and equipment requirements.
• Application-specific referral opportunities.
• Unserved clinical needs and geographic gaps.
• Portfolio expansion economics.

Technology, Geographic, Capacity and Channel Benchmarking: Integration Creates Defensible Local Advantages

Technology benchmarking evaluates digital scheduling, patient monitoring, clinical documentation, escalation procedures, and system integration. Geographic benchmarking assesses service coverage, population density, and access to hospitals, laboratories, and pharmacies. Capacity benchmarking measures concurrent patient capacity, annual admissions, workforce availability, and the ability to expand services without compromising clinical quality.

Customer and channel benchmarking examines relationships with hospital discharge teams, specialist departments, general practitioners, nursing homes, and other referral sources. Key performance indicators include referral volumes, referral acceptance rates, time from referral to admission, referral source concentration, and repeat referrals. Together, these measures reveal how effectively providers integrate clinical services, manage regional operations, and build reliable referral networks.

Key Coverage

• Digital maturity and interoperability.
• Regional capacity and facility coverage.
• Staffing-adjusted expansion potential.
• Hospital and residential-care partnerships.
• Referral conversion and partner concentration.
• Competitive white spaces by region and clinical application.

Strategic Developments and M&A: Partnership-Led Expansion Is a Critical Route to Scale

Strategic developments in the France Hospital-at-Home (HAD) market include new service launches, geographic expansion, hospital partnerships, digital investments, clinical specialization, and consolidation. Transaction analysis distinguishes acquisitions of dedicated HAD providers from broader healthcare acquisitions that include HAD operations.

The report examines strategic developments and transactions, separating completed deals from announced initiatives and HAD-specific transactions from wider healthcare sector activity. It also assesses how partnerships and consolidation strengthen technology integration, purchasing efficiency, workforce allocation, and referral networks to expand service capacity and improve operational performance.

Key Coverage

• Verified transactions and strategic partnerships.
• Regional expansion and service integration.
• Ownership changes affecting HAD operations.
• Digital investment and clinical capability development.
• Potential consolidation targets and acquisition rationale.
• Integration risks and post-merger operating synergies.

Opportunity & White-Space Analysis: The Largest Opportunities Lie in Converting Clinical Need Into Deliverable Capacity

The principal opportunity is not simply to increase the number of patients receiving home care. It is to expand the share of clinically eligible patients who can be treated at home through effective referrals, adequate staffing, and reliable service coverage.

Three opportunity pools stand out:

• Capacity expansion: Raising operational capacity in territories where hospital demand and suitable patient populations exceed available HAD provision.
• Clinical specialization: Developing capabilities in complex treatments that require coordinated nursing, medical supervision, pharmacy, and equipment support.
• Digital and operational integration: Reducing avoidable referral delays, improving scheduling and monitoring, and increasing staff productivity without compromising safety.

Key Coverage

• Untapped patient eligibility and referral conversion.
• Regional capacity gaps and staffing-adjusted expansion.
• High-complexity clinical pathways.
• Digital workflow and productivity improvements.
• Hospital and EHPAD partnership opportunities.
• Incremental revenue and investment scenarios.

Porter’s Five Forces

The report examines how these forces vary between densely populated urban territories and less densely served areas, and between generalist and clinically specialized providers.

PESTLE Analysis: Public Policy and Healthcare Workforce Conditions Shape Market Development

• Political: Continued emphasis on alternatives to conventional hospitalization supports HAD expansion, but implementation depends on regional healthcare priorities and public funding.
• Economic: Wage inflation, medicine costs, travel expenses, and budget constraints affect the viability of incremental patient-days.
• Social: Population ageing and preference for care at home support demand, while caregiver availability and housing suitability influence eligibility.
• Technological: Remote monitoring and integrated records improve coordination, provided they fit clinical workflows and support timely intervention.
• Legal: Healthcare authorization, prescribing, patient consent, reimbursement, and data protection define operating requirements.
• Environmental: Fewer inpatient stays may reduce some resource use, although staff travel and home-based logistics must be included in a complete assessment.

Market Attractiveness: Attractive Structural Demand, With Execution-Dependent Returns

Future Outlook: Patient-Day Growth Depends on Capacity, Clinical Scope and Funding

The outlook for the France Hospital-at-Home (HAD) market through 2035 depends on France’s ability to translate healthcare priorities into operational services, expand treatment capacity, and sustain funding.

The baseline scenario assumes steady patient-day growth driven by demographic changes and increased service capacity. The optimistic scenario reflects stronger referral conversion, higher workforce productivity, and broader adoption of clinically suitable treatments. The pessimistic scenario accounts for staff shortages, budget constraints, high service delivery costs, and delays in implementing new operating models.

Strategic priorities include strengthening referral networks, expanding clinically appropriate treatment categories, retaining qualified staff, improving digital integration, and monitoring financial performance at both patient-day and episode levels.

Key Coverage

• Upside, base and downside forecasts.
• Clinical specialization and treatment adoption.
• Workforce, capacity and reimbursement outlook.
• Regional expansion and competitive repositioning.
• Potential consolidation and future profit pools.

Recent Developments in the Market

In September 2026, France-based health tech start-up Relaisanté has closed a seed round worth €6 million. The company was founded earlier this year by Etienne Boix and Pierre Godet, and provides a platform for connecting recently discharged patients with healthcare professionals within 18 minutes.

https://dealroom.co/news/156170-frances-relaisant-raises-6m-to-place-home-carers-in-18-minutes/

In May 2026, since 25 April 2026, the term “Maison France Autonomie” has been coined to refer to the elderly care industry in France. The term has been coined by Camille Galliard-Minier, the French Minister Delegate for Autonomy and People with Disabilities, and is destined to become an alternative to EHPAD before 2027.

https://www.familizz.com/en/maison-france-autonomie-ehpad/

Key Strategic Questions Addressed

• Which clinical pathways account for the largest activity volumes and the greatest growth potential?
• How do reimbursement, patient mix, and treatment intensity affect provider economics?
• Where are the largest gaps between eligible patient demand and operationally available capacity?
• Which regions offer the strongest opportunities for expansion?
• How do workforce shortages and travel costs constrain scalable service delivery?
• Which providers have the strongest combination of clinical breadth, operating scale, and referral access?
• What proportion of national activity is concentrated among the leading providers?
• Which operational KPIs best explain differences in provider performance?
• Which partnerships and acquisition strategies accelerate regional expansion?
• What regulatory, reimbursement, and budget risks weaken the growth outlook?
• Which underserved patient groups and complex clinical applications represent the most compelling white spaces?
• What capacity, staffing, and partnership investments are required to capture the market's next phase of growth?

Segments Covered in the Report

By Service Type

• Medical and Nursing Care 
• Palliative and End-of-Life Care
• Cancer and Oncology Supportive Care
• Complex Wound Care
• Intravenous Therapy and Infusion Services
• Post-Acute and Post-Surgical Care
• Rehabilitation Services
• Maternal and Perinatal Care
• Infectious Disease Management
• Chronic Disease Management
• Other Specialized Clinical Services

By Clinical Application

• Oncology
• Palliative Care
• Cardiovascular Diseases
• Neurological Disorders
• Respiratory Diseases
• Infectious Diseases
• Diabetes and Metabolic Disorders
• Wound and Skin Conditions
• Post-Surgical Recovery
• Other Clinical Applications

By Patient Age Group

• Pediatric Patients
• Adult Patients (18-59 Years)
• Older Adults (60 Years and Above)

By Care Setting

• Private Residential Homes
• Nursing Homes and Long-Term Care Facilities (EHPAD)
• Assisted Living and Residential Care Facilities
• Other Eligible Residential Settings

By Patient Acuity and Care Complexity

• Low-Complexity Clinical Care
• Moderate-Complexity Clinical Care
• High-Complexity Clinical Care
• Intensive and Specialized Clinical Care

By Duration of Care

• Short-Term Care (Less Than 15 Days)
• Medium-Term Care (15-30 Days)
• Long-Term Care (More Than 30 Days)

By Referral Source

• Public Hospitals and University Hospital Centers (CHUs)
• Private Hospitals and Clinics
• General Practitioners
• Medical Specialists
• Emergency and Acute Care Departments
• Nursing Homes and Long-Term Care Facilities
• Other Healthcare Providers

By Provider Type

• Public Hospital-Based HAD Providers
• Private Nonprofit HAD Providers
• Private For-Profit HAD Providers
• Specialized Independent HAD Organizations

By Payment and Reimbursement Structure

• Regulated HAD Tariff-Based Reimbursement
• Case-Mix-Based Reimbursement
• Supplementary and Activity-Related Funding
• Other Applicable Healthcare Funding Mechanisms

By Technology

• Remote Patient Monitoring
• Teleconsultation and Telehealth
• Electronic Health Records and Digital Care Plans
• Clinical Scheduling and Coordination Software
• Connected Medical Devices
• Other Digital Healthcare Technologies

By Care Delivery Model

• Hospital-Integrated HAD Services
• Independent Specialist HAD Services
• Multidisciplinary Home-Based Clinical Care
• Digitally Supported and Remote-Monitoring-Enabled Care